Pierre J. Wolkenstein

Université Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 266 publications

Cherry Angiomas in Individuals With Neurofibromatosis Type 1.

Cherry Angiomas in Individuals With Neurofibromatosis Type 1.

Journal: JAMA dermatology

Published: August 19, 2026

A standardized imaging and analysis workflow for quantitative evaluation of cutaneous neurofibromas in Nf1-KO mice.

A standardized imaging and analysis workflow for quantitative evaluation of cutaneous neurofibromas in Nf1-KO mice.

Journal: PloS one

Published: April 19, 2026

Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model.

Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model.

Journal: Science advances

Published: November 12, 2025

Outcome measures for cutaneous neurofibromas in NF1: Insights from an international study.

Outcome measures for cutaneous neurofibromas in NF1: Insights from an international study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 04, 2025

Clinical benefits of selumetinib in adults with neurofibromatosis type 1 - Authors' reply.

Clinical benefits of selumetinib in adults with neurofibromatosis type 1 - Authors' reply.

Journal: Lancet (London, England)

Published: October 27, 2025

Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets.

Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets.

Journal: Acta neuropathologica communications

Published: October 23, 2025

Disease burden and unmet needs in adults with neurofibromatosis type 1 and plexiform neurofibromas: A systematic literature review.

Disease burden and unmet needs in adults with neurofibromatosis type 1 and plexiform neurofibromas: A systematic literature review.

Journal: Neuro-oncology advances

Published: August 04, 2025

Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D.

Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D.

Journal: The British journal of dermatology

Published: July 15, 2025

Neurofibromatosis type 1: recent advances

Neurofibromatosis type 1: recent advances

Journal: La Revue du praticien

Published: June 23, 2025

Phenotype of neurofibromatosis 1: a comparison study between NF1 mutant mice and humans.

Phenotype of neurofibromatosis 1: a comparison study between NF1 mutant mice and humans.

Journal: The Journal of investigative dermatology

Published: June 13, 2025

Hair follicle stem cell fate supports distinct clinical endotypes in hidradenitis suppurativa.

Hair follicle stem cell fate supports distinct clinical endotypes in hidradenitis suppurativa.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 02, 2025

Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASI.

Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASI.

Journal: Journal of the American Academy of Dermatology

Published: April 03, 2025

Showing 1-12 of 266

Last Updated: 09/26/2026